Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Molecules ; 26(1)2020 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-33396585

RESUMO

A suitable HPLC method has been selected and validated for rapid simultaneous separation and determination of four imidazole anti-infective drugs, secnidazole, omeprazole, albendazole, and fenbendazole, in their final dosage forms, in addition to human plasma within 5 min. The method suitability was derived from the superiority of using the environmentally benign solvent, methanol over acetonitrile as a mobile phase component in respect of safety issues and migration times. Separation of the four anti-infective drugs was performed on a Thermo Scientific® BDS Hypersil C8 column (5 µm, 2.50 × 4.60 mm) using a mobile phase consist of MeOH: 0.025 M KH2PO4 (70:30, v/v) adjusted to pH 3.20 with ortho-phosphoric acid at room temperature. The flow rate was 1.00 mL/min and maximum absorption was measured with UV detector set at 300 nm. Limits of detection were reported to be 0.41, 0.13, 0.18, and 0.15 µg/mL for secnidazole, omeprazole, albendazole, and fenbendazole, respectively, showing a high degree of the method sensitivity. The method of analysis was validated according to Food and Drug Administration (FDA)guidelines for the determination of the drugs, either in their dosage forms with highly precise recoveries, or clinically in human plasma, especially regarding pharmacokinetic and bioequivalence studies.


Assuntos
Anti-Infecciosos/química , Química Farmacêutica/métodos , Cromatografia Líquida de Alta Pressão/métodos , Imidazóis/análise , Albendazol/análise , Albendazol/sangue , Calibragem , Técnicas de Química Analítica , Formas de Dosagem , Fenbendazol/análise , Fenbendazol/sangue , Humanos , Concentração de Íons de Hidrogênio , Imidazóis/sangue , Metronidazol/análogos & derivados , Metronidazol/análise , Metronidazol/sangue , Omeprazol/análise , Omeprazol/sangue , Segurança do Paciente , Reprodutibilidade dos Testes , Solventes , Temperatura , Raios Ultravioleta , Estados Unidos , United States Food and Drug Administration
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...